Author:
Shih Hsin-I,Lin Ming-Chia,Lin Che-Chen,Hsu Hsiang-Chin,Lee Hsin-Ling,Chi Chih-Hsien,Sung Fung-Chang,Chang Yen-Jung,Kao Chia-Hung
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. American Psychiatric Association (1990) Benzodiazepine dependence, toxicity, and abuse: a task force report of the American Psychiatric Association. American Psychiatric Publishing, Washington
2. Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, Möller HJ, WFSBP Task Force on Mental Disorders in Primary Care; WFSBP Task Force on Anxiety Disorders, OCD and PTSD (2012) Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract 16:77–84
3. Baylé FJ, Blanc O, De Chazeron I, Lesturgeon J, Lançon C, Caci H, Garay RP, Llorca PM (2011) Pharmacological management of anxiety in patients suffering from schizophrenia. Encephale 37(Suppl 1):S83–S89
4. Berger A, Edelsberg J, Sanders KN, Alvir JM, Mychaskiw MA, Oster G (2012) Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: a retrospective cohort study. BMC Psychiatry 12:99
5. Carlsten A, Waern M, Holmgren P, Allebeck P (2003) The role of benzodiazepines in elderly suicides. Scand J Public Health 31:224–228
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献